¸ð½Ã´Â±Û ÇÁ·Î±×·¥ ÃÊ·ÏÁ¢¼ö »çÀüµî·Ï ¹ßÇ¥ÀÚ ¾È³» ¼ö»óÀÚ ¾È³» Çà»çÀå¾È³» ¼÷¹Ú¾È³» Ȩ
 2014³â 9¿ù 26ÀÏ(±Ý)

Convention Hall [4F]
07:00 µî·Ï
Breakfast Symposium ÁÂÀå : ±èÈï¿­(°í½ÅÀÇ´ë)
07:50-08:05 Long-term treatment of uterine fibroids with ulipristal aceatate
(Pearl III and extension study results repeated intermittent treatment with UPA 10mg)
±è¼ºÈÆ(¿ï»êÀÇ´ë)
08:20-10:20 ÀϹݿ¬Á¦
10:20-10:40 Coffee Break
Á¦100Â÷ ´ëÇÑ»êºÎÀΰúÇÐȸ Çмú´ëȸ °³È¸½Ä
10:40-11:00 Àλ縻 & °ø·ÎÆÐÁõÁ¤ À±¼ºµµ(´ëÇÑ»êºÎÀΰúÇÐȸ ȸÀå)
±èÀåÈí(´ëÇÑ»êºÎÀΰúÇÐȸ ÀÌ»çÀå)
ÃÊû°­¿¬ I ÁÂÀå : À̱ٿµ(ÇѸ²ÀÇ´ë)
ÀÌÇÊ·®(¿ï»êÀÇ´ë)
11:00-11:25 Infertility a Global Health problem Chittaranjan Narahari Purandare
(President Elect of FIGO)
11:25-11:50 The Role of FIGO in Global Women¡¯s Health Hamid Rushwan(Chief Executive of FIGO)
11:50-12:10 ¸í¿¹È¸¿ø Ãß´ë½Ä Noriaki Sakuragi(Japan)
Ching-Hung Hsieh(Taiwan)
ÃÊû°­¿¬ II ÁÂÀå : ÀåÀ±¼®(¸¶¸®¾Æº´¿ø)
³²±Ã¼ºÀº(°¡Å縯ÀÇ´ë)
12:10-12:35 QOL-oriented Surgery for Patients with Cervical Cancer Noriaki Sakuragi(Japan)
12:35-13:00 Urinary frequency treatment strategy Ching-Hung Hsieh(Taiwan)
Luncheon Symposium ÁÂÀå : ±è¿µÅÂ(¿¬¼¼ÀÇ´ë)
13:00-14:00 HPV diseases burden and value of qHPV Vaccine in real world ÁÖ¿ø´ö(Â÷ÀÇ°úÇдë)
Ưº°°­¿¬ I ÁÂÀå : ±è¼®Çö(¼­¿ïÀÇ´ë)
±è Ź(°í·ÁÀÇ´ë)
14:00-14:20 Current practice pattern in managing AUB: Korean national survey of ObGyns Ãֵμ®(¼º±Õ°üÀÇ´ë)
14:20-14:40 Clinical experience and long term use of Visanne ÀÌÁ¤·Ä(¼­¿ïÀÇ´ë)
Ưº°°­¿¬ II ÁÂÀå : °í¹Îȯ(À»ÁöÀÇ´ë)
¹è´ö¼ö(¼º±Õ°üÀÇ´ë)
14:40-15:00 Clinical experience of US-guided HIFU Treatment for Uterine Fibroid & Adenomyosis Tang Liangdan(Chongqing Medical Univ)
15:00-15:20 HPV DNA confirmÀ» À§ÇÑ Real Time PCR ÃÖÁ¾Çö(¾¾Á¨ÀÇ·áÀç´Ü)
15:20-15:40 Coffee Break
17:30 Banquet